Search Results

You are looking at 61 - 70 of 152 items for :

Clear All
Full access

Robert J. Motzer, Neeraj Agarwal, Clair Beard, Graeme B. Bolger, Barry Boston, Michael A. Carducci, Toni K. Choueiri, Robert A. Figlin, Mayer Fishman, Steven L. Hancock, Gary R. Hudes, Eric Jonasch, Anne Kessinger, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Bruce G. Redman, Cary N. Robertson, Lawrence H. Schwartz, Joel Sheinfeld and Jue Wang

Hollingsworth JM Miller DC Dunn RL . Surgical management of low-stage renal cell carcinoma: technology does not supersede biology . Urology 2006 ; 67 : 1175 – 1180 . 10 Shuch B Lam JS Belldegrun AS . Open partial nephrectomy for the treatment or

Full access

Andrew K. Lee and Christopher L. Amling

preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer . Urology 2000 ; 55 : 572 – 577 . 7. D'Amico AV Cote K Loffredo M

Full access

Philip J. Saylor and Matthew R. Smith

. 11. Vogelzang NJ Chodak GW Soloway MS . Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group . Urology 1995 ; 46 : 220 – 226

Full access

Peter E. Clark, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff Michalski, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Philippe E. Spiess, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary Dwyer and Maria Ho

on Urologic Diseases-European Association of Urology evidence-based guidelines. 55 There is an apparent underuse of aggressive bladder-preserving therapies for noncystectomy candidates, especially the elderly and racial minorities. 56 Between 23

Full access

Waleed A. Hassen, Farrok A. Karsan, Farhat Abbas, Yasar Beduk, Ahmed El-Khodary, Marwan Ghosn, Jamal Khader, Raja Khauli, Danny M. Rabah, Ali Shamseddine and Sandy Srinivas

://www-naweb.iaea.org/nahu/dirac/default.asp . Accessed March 31, 2010 . 8. Smith DC Redman BG Flaherty LE . A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer . Urology 1998 ; 52 : 257 – 260 .

Full access

James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Anthony V. D’Amico, Brian J. Davis, Tanya Dorff, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric Mark Horwitz, Michael Hurwitz, Joseph E. Ippolito, Christopher J. Kane, Michael R. Kuettel, Joshua M. Lang, Jesse McKenney, George Netto, David F. Penson, Elizabeth R. Plimack, Julio M. Pow-Sang, Thomas J. Pugh, Sylvia Richey, Mack Roach III, Stan Rosenfeld, Edward Schaeffer, Ahmad Shabsigh, Eric J. Small, Daniel E. Spratt, Sandy Srinivas, Jonathan Tward, Dorothy A. Shead and Deborah A. Freedman-Cass

, Pierorazio PM , Han M , . Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system . Urology 2012 ; 80 : 1075 – 1079 . 10.1016/j.urology.2012.07.040 22995570 88. Muralidhar V , Chen MH

Full access

Masaki Shiota

Shiota, MD, PhD, is a Junior Associate Professor in the Department of Urology at Kyushu University, Fukuoka, Japan. Dr. Shiota has expertise in urological oncology, especially prostate cancer. He has worked on basic, translational, and clinical research

Full access

Miren Gaztañaga and Juanita Crook

Shields A Wood N . Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression . Urology 2004 ; 64 : 1182 – 1186 . 9 Keating NL O’Malley AJ Smith MR . Diabetes and

Full access

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam Chang, Tracy M. Downs, Jason A. Efstathiou, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman-Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Jonathan Tward, Jonathan L. Wright, Lisa A. Gurski and Alyse Johnson-Chilla

–muscle-invasive bladder cancer. 64 Several organizations, including the American Urological Association (AUA), American Association of Clinical Urologists (AACU), Bladder Cancer Advocacy Network (BCAN), Society of Urologic Oncology (SUO), the Large Urology Group Practice

Full access

Eleni Efstathiou and Christopher J. Logothetis

reproductive hormones before and after orchiectomy in men with testicular cancer . J Urol 1999 ; 161 : 822 – 826 . 52. Guazzieri S Lembo A Ferro G . Sperm antibodies and infertility in patients with testicular cancer . Urology 1985 ; 26 : 139